Why Cannabis Science Inc Is Making A Noise? (OTCMKTS:CBIS)

Cannabis Science Inc (OTCMKTS:CBIS) reported the publication of initial research data on utilizing nanoparticle drones to target lung cancer with cannabinoids and radiosensitizers in the journal Frontiers in Oncology. This publication addresses drug delivery, and showcases an innovative plan to transport CBDs directly to cancer cells with minimal side effects or toxicities that have so far hindered clinical translation initiatives.

The article is a preliminary outcome of growing company’s collaborative work and speaks to a major deduction from the National Academies of Sciences, Engineering, & Medicine 2017 report on the impact of cannabis and cannabinoids grounded on the prevailing state of evidence and references for research.

The details

Raymond C. Dabney, the CEO and President of Cannabis Science, expressed that the laboratory work from company’s collaborations are moving apace and more data will be reported soon. Currently, initial date indicates that using smart drug-delivery mechanisms to offer CBDs directly to tumor cells results in amplified tumor cell kill in animal models of pancreatic cancer and lung cancer, which are some of the lethal cancers. This report is being prepared for presentation and publication at upcoming international and national conferences.

The unique drug delivery plan for CBDs is consistent with the three key elements in company’s drug development program: The first element is defining the specificity and effectiveness of cannabinoids being tested; Secondly, testing and identifying drug delivery mechanisms; and last evaluating and testing the impact of co-interventions, and the use of additional therapeutic and/or diagnostic procedures to members in randomized controlled studies. Cannabis Science preliminary data point to the significance of drug delivery systems and the influence of co-interventions.

Allen A. Herman, the CMO of Cannabis Science, expressed that this publication highlights their preliminary work and they are assiduously working on utilizing their drug delivery system to assess the effect of cannabinoids without and with radiation therapy on pancreatic and lung cancer.

%d bloggers like this: